Sep 2026· Talanta: The International Journal of Pure and Applied Analytical Chemistry· Vol 313 Pt B, pp.
130655
· 0 citations· 28 references
Medicine
TL;DR
A Cas12a-RCA ratiometric sensing platform (CRRSP) for the quantitative detection of the DR-associated biomarker miR-1281 and shows excellent agreement with RT-qPCR in clinical serum samples from healthy controls, glaucoma patients, and patients with non-proliferative diabetic retinopathy (NPDR) or proliferative diabetic retinopathy (PDR).
Abstract
Diabetic retinopathy (DR) is a major microvascular complication of diabetes, yet accessible molecular tools for early-stage screening remain limited. Circulating microRNAs are promising non-invasive biomarkers for DR, but their reliable quantification in serum is hindered by low abundance, matrix interference, and limited robustness of single-signal assays. Here, we report a Cas12a-RCA ratiometric sensing platform (CRRSP) for the quantitative detection of the DR-associated biomarker miR-1281. The assay is constructed using a target-triggered cascaded strand-displacement circuit that enforces sequential molecular recognition prior to amplification, thereby improving specificity. Upon target recognition, rolling circle amplification (RCA) generates DNA products that simultaneously produce a thioflavin T (ThT) fluorescence signal via G-quadruplex (G4) formation and sequester the Cas12a/gRNA Activator strand to suppress ROX fluorescence. This dual-channel ThT/ROX readout enables intrinsic ratiometric normalization, effectively compensating for matrix effects and experimental variability. The workflow operates under sequential constant-temperature steps without PCR-type thermal cycling. The assay achieves a detection limit of 0.83 pM with high selectivity and shows excellent agreement with RT-qPCR in clinical serum samples from healthy controls, glaucoma patients, and patients with non-proliferative diabetic retinopathy (NPDR) or proliferative diabetic retinopathy (PDR).
MicroRNA signatures provide an informative readout of host-response dysregulation in pediatric sepsis, but their clinical translation remains limited by low target abundance and multiplexing requirements. Here, a target amplification-free CRISPR biosensing platform was established. The sensing mechanism couples Cas13a...
Di Huang, Shan-Shan Shi, Xi-Tong Wang et al.· Biosensors & bioelectronics· 0 citations
Alzheimer's disease (AD) is associated with pathological changes that can occur years before the onset of clinical symptoms, highlighting the importance of sensitive biomarker detection for early diagnosis. Here, we developed a fluorescence biosensing platform based on CRISPR/Cas13a-assisted hyperbranched rolling circl...
Juan Song, Hui-Xin Yue, Chuan-Song Zhang et al.· Talanta: The International J...· 0 citations
MicroRNA-21 is a well recognized oncogenic microRNA and is involved in the initiation and development of many cancers, making it an important candidate marker for diagnosis. In this work, a label-free fluorescent assay was designed for highly sensitive miRNA-21 detection by coupling exponential amplification reaction (...
This magnetic bead-assisted duplex-specific nuclease-specific nuclease (DSN) cleavage strategy coupled with CRISPR/Cas12a fluorescence biosensing for sensitive miR-122 detection provides a simple, sensitive, and specific platform for miR-122 detection, holding promise for liver disease-related diagnostic applications.
Zhen Yu, Jin Wang, Y. An et al.· Analytical Methods· 0 citations
An entropy-driven amplification (EDA) coupled CRISPR-Cas12a dual-mode biosensor was established for sensitive detection of breast cancer biomarker miR-155 and shows favorable anti-interference performance in diluted healthy human serum spike-recovery tests.
Yi-Hua Wang, Min Lan, Min Zhong et al.· Microchimica Acta· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.